glp 1 drugs for weight loss How GLP-1 medications are transforming diabetes and treatment GLP-1 Agonists: A Comprehensive Overview

Chlorogenic acid, a polyphenol, has demonstrated multiple mechanisms through which it exerts antidiabetic activity, including inhibition of alpha-glucosidase and the glucose-elevating liver enzyme glucose-6-phosphatase, oxidative stress modulation, insulin sensitization, and AMPK activation (Bassoli 2008

C.WentaM

CB1R mostly resides in the central nervous system (CNS) while the CB2R receptors are mostly expressed in the immune cells such as natural killer cells, neutrophils, and monocytes as well as other tissues such as the bladder, intestine, etc

BPC 157 (Body Protection Compound-157) is a synthetic pentadecapeptide, meaning it is composed of a sequence of 15 amino acids